Abstract
Toxicity databases are a useful resource to support hazard and risk assessment. They are used to retrieve historical studies for compounds of interest and to support toxicity predictions where no data exists. Toxicity predictions are either based upon study results from similar chemicals or prediction models built from these databases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dimitrov S, Mekenyan O (2010) An introduction to read-across for the prediction of effects of chemicals. In: Cronin MTD, Madden JC (eds) In silico toxicology: principles and applications. The Royal Society of Chemistry, Cambridge, pp 372–384
van Leeuwen K, Schultz TW, Henry T, Diderich R, Veith GD (2009) Using chemical categories to fill data gaps in hazard assessment. SAR QSAR Environ Res 20:207–220
Cronin MTD (2013) An introduction to chemical grouping, categories and read across to predict toxicity. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (eds) Chemical toxicity prediction: category formation and read-across applications. The Royal Society of Chemistry, Cambridge, pp 1–29
Cronin MTD (2013) Evaluation of categories and read-across for toxicity prediction allowing for regulatory acceptance. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (eds) Chemical toxicity prediction: category formation and read-across applications. The Royal Society of Chemistry, Cambridge, pp 155–167
Myatt GJ, Cross KP (2015) In silico solutions for predicting efficacy and toxicity. In: Coleman R (ed) Human-based systems for translation research. Royal Society of Chemistry, London, UK
Benfenati E (2012) E-Book: theory, guidance and applications on QSAR and REACH, ISBN 978-88-902405-4-6; Orchestra Project website: http://www.orchestra-qsar.eu/documents/333
Dearden JC, Barratt MD, Benigni R, Bristol DW, Combes RD, Cronin MTD, Judson PN, Payne MP, Richard AM, Tichy M, Worth AP, Yourick JJ (1997) The development and validation of expert systems for predicting toxicity. Altern Lab Anim 25:223–252
Daston G, Knight DJ, Schwarz M, Gocht T, Thomas RS, Mahony C, Whelan M (2015) SEURAT: safety evaluation ultimately replacing animal testing — recommendations for future research in the field of predictive toxicology. Arch Toxicol 89(1):15–23
Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, Schilter B, Schlatter J, van Schothorst F, Vos JG, Wurtzen G (2004) Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet. Food Chem Toxicol 42:65–83
Dix DJ, Houck KA, Martin MT, Richard AM, Setzer RW, Kavlock RJ (2007) The ToxCast program for prioritizing toxicity testing of environmental chemicals. Toxicol Sci 95(1):5–12
Sweet DV, Anderson VP, Fang JCF (1999) An overview of the registry of toxic effects of chemical substances (RTECS): critical information on chemical hazards. Chem Health Saf 6(6):12–16
Russom CL, Bradbury SP, Broderius SJ, Hammermeister DE, Drummond RA (1997) Predicting modes of action from chemical structure: acute toxicity in the fathead minnow (Pimephales promelas). Environ Toxicol Chem 16(5):948–967
http://www.niehs.nih.gov/research/resources/databases/cebs/index.cfm
Estrada E, Patlewicz G, Chamberlain M et al (2003) Computer-aided knowledge generation for understanding skin sensitization mechanisms: the TOPS-MODE approach. Chem Res Toxicol 16:1226–1235
Leadscope SAR Genetox Database 2015 User Guide
FDA CDER FOI site: http://www.accessdata.fda.gov/scripts/cder/drugsatfda. Accessed 16 May 2015
Food and Drug Administration CFSAN EAFUS (2007) U.S. FDA Center for food safety and applied nutrition, everything added to food in the United States. http://www.fda.gov/food/ingredientspackaginglabeling/ucm115326.htm. Accessed 16 May 2015
Tennant RW (1991) The genetic toxicity database of the National Toxicology Program: evaluation of the relationships between genetic toxicity and carcinogenicity. Environ Health Perspect 96:47–51
CCRIS. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?CCRIS. Accessed 5 June 2010
Tokyo-Eiken (2007) Tokyo Metropolitan Institute of Public Health, Mutagenicity of food additives
Ali M, Patel M, Wilkinson D, Judson P, Cross K, Bower D (2013) ToxML, a data exchange standard with content controlled vocabulary used to build better (Q)SAR models. SAR QSAR Environ Res 24(6):429–438
Ashby J, Tennant RW (1988) Chemical structure, Salmonella mutagenicity and extent of carcinogenicity as indicators of genotoxic carcinogenesis among 222 chemicals tested by the U.S.NCI/NTP. Mutat Res 204:17–115
Durant JL, Leland BA, Henry DR, Nourse JG (2002) Reoptimization of MDL keys for use in drug discovery. J Chem Inf Comput Sci 42(6):1273–1280
Johnson DE, Blower PE, Myatt GJ, Wolfgang G (2001) Chem-tox informatics: data mining using a medicinal chemistry building block approach. Curr Opin Drug Disc Develop 4(1):92–101
Roberts G, Myatt GJ, Johnson WP, Cross KP, Blower PE Jr (2000) LeadScope: software for exploring large sets of screening data. J Chem Inf Comput Sci 40(6):1302–1314
Cross KP, Myatt G, Yang C, Fligner MA, Verducci JS, Blower PE Jr (2003) Finding discriminating structural features by reassembling common building blocks. J Med Chem 46(22):4770–4775
Blower PE, Cross KP (2006) Decision tree methods in pharmaceutical research. Curr Top Med Chem 6(1):31–39, Review
Barnard JM, Downs GM (1992) J Chem Inf Comput Sci 32:644
Blower PE Jr, Cross KP, Fligner MA, Myatt GJ, Verducci JS, Yang C (2004) Systematic analysis of large screening sets in drug discovery. Curr Drug Discov Technol 1(1):37–47
Benigni R, Bossa C (2011) Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. Chem Rev 111(4):2507–2536
Enoch S, Cronin MT (2010) A review of electrophilic reaction chemistry involved in covalent DNA binding. Crit Rev Toxicol 40:728–748
Shamovsky I et al (2011) Explanation for main features of structure-genotoxicity relationships of aromatic amines by theoretical studies of their activation pathways in CYP1A2. J Am Chem Soc 133(40):16168–16185
http://tools.niehs.nih.gov/cebs3/ntpViews/?activeTab=detail&studyNumber=636704
http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+ccris:@term+@rn+81-11-8
http://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+ccris:@term+@rn+81-11-8
http://tools.niehs.nih.gov/cebs3/ntpViews/?activeTab=detail&studyNumber=121112
http://tools.niehs.nih.gov/cebs3/ntpViews/?activeTab=detail&studyNumber=150557
http://tools.niehs.nih.gov/cebs3/ntpViews/?activeTab=detail&studyNumber=797992
Geladi P, Kowalski B (1986) Partial least-squares regression: a tutorial. Anal Chim Acta 1(17):185
Yang C, Cross KP, Myatt GJ, Blower PE, Rathman JF (2007) Building predictive models for protein tyrosine phosphatase 1B inhibitors based on discriminating structural features by reassembling medicinal chemistry building blocks. J Med Chem 47(24):5984–5994
Leadscope I (2009) Leadscope enterprise predictive data miner documentation. Leadscope, Columbus, OH
Leadscope, Inc (2014) Leadscope user guide. Leadscope, Columbus, OH
United Nations (2011) Globally harmonized system of classification and labelling of chemicals, 4th edn. United Nations, New York/Geneva
Cefic (2002) (Q)SARs for human health and the environment. In: Workshop Report on Regulatory acceptance of (Q)SARs Setubal, Portugal, Accessed 4–6 Mar 2002
Sutter A, Amberg A, Boyer S, Brigo A, Contrera JF, Custer LL, Dobo KL, Gervais V, Glowienke S, van Gompel J, Greene N, Muster W, Nicolette J, Reddy MV, Thybaud V, Vock E, White AT, Muller L (2013) Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities. Regul Toxicol Pharmacol 67:39–52
Dobo KL, Greene N, Fred C, Glowienke S, Harvey JS, Hasselgren C, Jolly R, Kenyon MO, Munzner JB, Muster W, Neft R, Reddy MV, White AT, Weiner S (2012) In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey. Regul Toxicol Pharmacol 62:449–455
Kruhlak NL, Benz RD, Zhou H, Colatsky TJ (2012) (Q)SAR modeling and safety assessment in regulatory review. Clin Pharmacol Ther 91:529–534
Naven RT, Greene N, Williams RV (2012) Latest advances in computational genotoxicity prediction. Expert Opin Drug Metab Toxicol 8:1579–1587
Powley MW (2015) (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission. Regul Toxicol Pharmacol 71:295–300
ICH (2014) ICH M7 – assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk
Cross KP, Myatt GJ, Bower DA, Miller S (2015) Evaluating expert opinions for ICH M7 compliant regulatory submissions created using an automated framework poster presented at the society of toxicology meeting
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Myatt, G.J., Quigley, D.P. (2016). Taking Advantage of Databases. In: Benfenati, E. (eds) In Silico Methods for Predicting Drug Toxicity. Methods in Molecular Biology, vol 1425. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3609-0_17
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3609-0_17
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3607-6
Online ISBN: 978-1-4939-3609-0
eBook Packages: Springer Protocols